Antimicrobial Agent Use

Treatment Pathways

Accessibility controls

Pause motion

Motion: On

Play motion

Motion: Off

Increase text contrast

Contrast: Standard

Reset text contrast

Contrast: High

Apply site-wide

Our Treatment Pathways are based on national guidelines and consensus statements, expert opinions from the Infectious Diseases team (pharmacy and medicine), and microbiology data from the microbiology laboratory.

Aminoglycosides

• Aminoglycoside High Dose Once Daily (HDOD) and Monitoring in Adult Patients

Antimicrobials for Surgery

•  Surgical Decolonization and Prophylaxis

Duration of Therapy

• Antimicrobial Duration of Therapy

Febrile Neutropenia

• Febrile Neutropenia

Guidelines for Restricted  Antimicrobials

• Guidelines for Restricted Antimicrobials 

For Antibiotics

• Ceftaroline
• Ceftazidime
• Ceftolozane
• Colistin 
• Dalbavancin
• Daptomycin
• Delafloxacin (Baxdela)
• Ertapenem
• Fidaxomicin
• Fosfomycin
• Linezolid
• Meropenem and Vaborbactam (Vabomere)
• Oritavancin
• Polymyxin B
• Colistin (Polymyxin E or Colistimethate)
• Tedizolid
• Tigecycline

For Antifungals

• Liposomal Amphotericin B
• Caspofungin
• Isavuconazonium sulfate
• Voriconazole

Monoclonal Antibody

• Bezlotoxumab (Zinplava)

Infection Control

• Infection Control

IV to PO Step-Down

• IV to PO Step-Down Guidelines

PK Calculations

• Pharmacokinetic Calculations

Renal Dosage Adjustments

• Antimicrobial Dosing Guidelines for Adult Patients Based on Renal Function

Vancomycin

• Guidelines for Vancomycin Dosing and Determination of Trough Levels in Adult Patients